Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults

A live attenuated zoster vaccine (ZOSTAVAX™, Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the vaccine has not been assessed in Korean population. This is multi-center, open-label, single-arm study performed with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Korean Med Sci
Main Authors: Choi, Won Suk, Choi, Jung-Hyun, Choi, Jun Yong, Eom, Joong Sik, Kim, Sang Il, Pai, Hyunjoo, Peck, Kyong Ran, Sohn, Jang Wook, Cheong, Hee Jin
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://ncbi.nlm.nih.gov/pubmed/26770032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.1.13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados